In this regard, it is necessary to implement research not only on these and new prognostic factors of tumor biology and of the tumor immune microenvironment, but on the pathophysiology of GH secretion, which may represent a target for future molecular therapies (7, 101, 102). This evidence concerns the gene GH1 and neoplasm.